Elsevier

Journal of Voice

Volume 15, Issue 1, March 2001, Pages 105-114
Journal of Voice

Articles
Voice Quality Changes Following Phonatory-Respiratory Effort Treatment (LSVT®) Versus Respiratory Effort Treatment for Individuals with Parkinson Disease

https://doi.org/10.1016/S0892-1997(01)00010-8Get rights and content

Abstract

Perceptual ratings of hoarseness and breathiness were used to assess the efficacy of two intensive methods for treating dysarthrophonia in individuals with idiopathic Parkinson disease. One method emphasized phonatory-respiratory effort (the Lee Silverman Voice Treatment, LSVT®) and the other emphasized respiratory effort alone (RET). Perceptual ratings were performed by two expert listeners based on random order presentation of the patients' pretreatment and posttreatment recordings of the “Rainbow Passage.” The listeners were blinded to the patients and their treatment group. Statistically significant pretreatment to posttreatment improvement in hoarseness and breathiness was observed in the LSVT® group but not in the RET group. The present findings are consistent with acoustic and physiologic findings reported previously, providing further evidence for the efficacy of the LSVT®.

Introduction

Parkinson disease (PD) is a progressive neurological disease caused by dopamine deficiency in the substantia nigra.1 Approximately 1.5 million individuals in the United States suffer from PD, and at least 75% of them have voice and speech abnormalities related to their disease.2, 3, 4 Some of these abnormalities, for example, breathy phonation, hoarseness, reduced loudness, imprecise articulation, and reduced prosody are likely to affect speech intelligibility, which in turn may adversely affect the patient's communication and social, economic, and psychological well-being.5, 6, 7

Traditional speech therapy methods for dysarthric individuals with PD, typically administered once or twice a week and emphasizing articulation, rate, and prosody intervention, have been largely ineffective.8, 9 In contrast, intensive voice therapy methods, administered almost daily and emphasizing simple phonatory effort tasks, have been found to produce favorable, long-term results in dysarthric individuals with PD.10, 11, 12

In 1987 Ramig et al.13 developed an intensive treatment program to improve vocal fold adduction and overall voice and speech production in individuals with PD. The program, known as the Lee Silverman Voice Treatment, or LSVT®, is unique in that it focuses on a simple set of tasks designed to maximize phonatory and respiratory functions. This is done by instructing and constantly stimulating individuals to produce good quality loud voice with maximum effort during sustained phonation and in various speech tasks. These individuals are also constantly reminded to monitor the loudness of the voice and the effort it takes to produce it.14, 15

The loud and effortful phonatory tasks with the LSVT® are aimed at improving respiratory drive, vocal fold adduction, and more generally laryngeal muscle activity and synergy, laryngeal and supralaryngeal articulatory movements, and vocal tract configuration. These physiologic changes should improve voice quality and intensity, articulatory precision, prosodic inflection, resonance, and speech intelligibility. Such changes accompanying loud phonation are expected based on similar effects seen in nondisordered speakers.7, 16, 17

The implementation of high-effort, intensive phonatory-respiratory therapy is based on evidence from clinical practices in neurology and physical therapy18, 19, 20 suggesting that when individuals with PD are pushed to higher effort levels, they learn to compensate for, or overcome, some of the deficits that underlie their motor impairment. This increase in effort level, especially when practiced intensively and daily, appears to help individuals with PD rescale or upscale the magnitude of their motor output, as seen in improved letterstroke in writing and stride length in walking.21, 22, 23 In line with certain principles of motor learning,24, 25, 26, 27 Ramig and her colleagues28 have argued that intensive high-effort treatment of vocal functions, especially when coupled with proprioceptive feedback and auditory-vocal self-monitoring, should help individuals with PD rescale the magnitude of their speech motor output and habituate this level in conversation. Emphasis on self-monitoring is an important part of the treatment since motor deficits in individuals with PD appear to be related to factors such as impaired sensorimotor processing, inability to appropriately scale and regulate movement parameters, reduced ability to automatically execute learned motor plans, impairment in effort-demanding processes, and other abnormalities involving high-level executive functions.23, 29, 30, 31, 32, 33, 34, 35

Several acoustic, aerodynamic, stroboscopic, and electroglottographic studies have demonstrated significant improvement in glottic closure, vocal fold vibratory movements, sound pressure level (SPL), and voice fundamental frequency (F0) range and modulations following LSVT®.28, 36, 37 In a study where LSVT® was compared with an alternative treatment method that emphasizes high respiratory effort treatment (RET), the former method proved superior to the latter in improving SPL and phonatory function.36 For example, whereas LSVT® significantly increased vocal fold adduction and SPL, RET produced inconsistent results, with some patients showing slight or moderate increases in SPL and vocal fold adduction, and others showing marked decreases in these variables posttreatment.

From a clinical standpoint, it is important to study perceptual changes that occur in voice and speech following treatment. Preliminary perceptual studies have already documented improvement in voice loudness, pitch inflection, speech intelligibility, and functional communication following LSVT®.14, 28, 36 To our knowledge, perceptual changes in voice quality following LSVT® have not been experimentally studied. Such information is important since abnormal voice quality can impact significantly on speech intelligibility and acceptability.7

The purpose of the present study was to assess the effects of LSVT® and RET on the perception of voice quality in individuals with idiopathic PD. Two percepts of voice quality were chosen for the study—hoarseness and breathiness. These percepts characterize the voices in many individuals with PD. They are likely to be related to incomplete vocal fold adduction; reduced laryngeal muscle activation or synergy; muscle atrophy or fatigue; asymmetrical vocal fold tension or movements; stiffness or rigidity, or a combination of these.37, 38, 39, 40, 41, 42

Acoustically, hoarseness and breathiness are characterized by excessive aperiodic energy superimposed on periodic (harmonic) energy.43 In general, breathiness reflects transglottal air turbulence due to incomplete glottic closure, and hoarseness reflects irregular and asymmetrical vocal fold vibration.43, 44, 45 Although hoarseness and breathiness are, to some degree, perceptually distinct, there is a considerable overlap between them in terms of their acoustic and physiologic characteristics.46, 47, 48

Studies in normal adult speakers have shown that as one increases loudness from normal to high levels, there tend to be significant increases in SPL, subglottal air pressure, transglottal airflow, vibratory movement of the vocal folds, and glottal closure, and significant decreases in jitter and shimmer (acoustic indices of abnormal voice quality) as well as in breathiness or hoarseness.16, 45, 49, 50, 51, 52, 53, 54 There is also evidence that increasing voice intensity by vocal fold medial adduction and compression (through the contraction of the lateral cricoarytenoid, interarytenoid, and thyroarytenoid muscles) is more efficient than by increasing transglottal airflow or vocal fold tension.55, 56, 57, 58 Given these facts, and given the differential effects of LSVT® and RET treatments on acoustic and physiologic measures mentioned above, one would expect to observe significant improvement in voice quality following LSVT® and to a lesser degree following RET.

While anticipated that the LSVT® will produce a more favorable effect on voice quality, it is possible that as patients attempt to increase loudness, they may induce excessive medial compression or tension in the vocal folds, or excessive transglottal airflow. These physiologic changes may result in an increase in breathiness or hoarseness, and possibly phonotrauma.42, 59 Thus, one might argue that the RET may be a more reasonable approach to improve voice quality since it increases respiratory drive with less phonatory adjustments which might be conducive to phonatory trauma and dysphonia.

Another reason for comparing the two treatment methods was to assess the potential influences of extraneous variables such as the Hawthorne or placebo effects on treatment outcome. We reasoned that if the two treatment methods yielded different results, such differences are less likely to be related to extraneous effects and more likely to be attributed to treatment-specific mechanisms.

Section snippets

Subjects

Initially, 45 individuals with idiopathic PD were included in the study and their voices were perceptually rated as described below. These individuals had sought treatment for voice and/or speech problems associated with their PD and were randomly assigned to either LSVT® or RET program after stratification for stage, duration, and severity of disease and age as discussed below. Many of these individuals had a pretreatment voice that was only mildly breathy or hoarse. To prevent possible

Results

The results are summarized in Table 2. This table shows the mean and standard deviation (in parentheses) of voice ratings and the percent change from pretreatment to posttreatment ratings for the two dependent variables (hoarseness and breathiness) in the LSVT® and RET groups. Percent change was calculated for each subject by subtracting the posttreatment measure from the pretreatment measure and dividing this difference by the largest of the two measures. The minus sign before the % change in

Discussion

In this perceptual study, individuals with PD treated with LSVT® showed a significant reduction in hoarseness and breathiness posttreatment. This finding is consistent with acoustic and physiologic data reported earlier 14, 37, 70, 71, 72 attesting to the efficacy of the LSVT® in the treatment of phonatory abnormalities associated with PD.

The lack of significant improvement in the RET group is more difficult to interpret. One possible explanation is that the sample size was too small and the

Acknowledgements

The research presented here was supported by National Institutes of Health grant No. R01DC01150. Our deepest gratitude is extended to the subjects who participated in this research study. The authors would like to thank Dr. Christopher Dromey, Dr. Kristin Baker, Dr. Susan Hensley, and Ms. Annette Pawlas for their assistance during various parts of this research.

References (74)

  • M Oxtoby

    Parkinson's disease patients and their social needs

    (1982)
  • L Ramig

    The role of phonation in speech intelligibility: A review and preliminary data from patients with Parkinson's disease

  • S Hoberman

    Speech techniques in aphasia and Parkinsonism

    J Michigan State Med Soc

    (1958)
  • G LeDorze et al.

    The effects of speech and language therapy for a case of dysarthria associated with Parkinson's disease

    Eur J Disord Commun

    (1992)
  • J Johnson et al.

    Speech therapy and Parkinson's disease: a review and further data

    Brit J Disord Commun

    (1990)
  • S Robertson et al.

    Speech therapy in Parkinson's disease: a study of the efficacy and long-term effect of intensive treatment

    Brit J Disord Commun

    (1984)
  • S Scott et al.

    Speech therapy for Parkinson's disease

    J Neurol Neurosurg Psychiatry

    (1983)
  • Ramig L, Mead C, Scherer R, Horii Y, Larson K, Kohler D. Voice therapy and Parkinson's disease: a longitudinal study of...
  • L Ramig et al.

    Voice treatment for patients with Parkinson disease: development of an approach and preliminary efficacy data

    J Med Speech-Lang Pathol

    (1994)
  • Ramig L, Pawlas A, Countryman, S. The Lee Silverman Voice Treatment (LSVT®): A Practical Guide to Treating the Voice...
  • C Dromey et al.

    Intentional changes in sound pressure level and rate: their impact on measures of respiration, phonation, and articulation

    J Speech Hear Res.

    (1998)
  • R Schulman

    Articulatory dynamics of loud and normal speech

    J Acoust Soc Am.

    (1989)
  • A England et al.

    The management of Parkinson's disease

    AMA Arch Intern Med

    (1959)
  • M Hallet et al.

    A psychological mechanism of bradykinesia

    Brain

    (1959)
  • F McDowell et al.

    Extrapyramidal disease

  • V Brooks

    The Neural Basis of Motor Control

    (1986)
  • F Muller et al.

    Scaling problems in Parkinson's disease

  • G Stelmach

    Basal ganglia impairment and force control

  • J Adams

    A closed-loop theory of motor learning

    J Motit Behav

    (1971)
  • J Adams

    Use of the model's knowledge of the results to increase observer's performance

    J Hum Mov Studies

    (1986)
  • R Schmidt

    A schema theory of discrete motor skill learning

    Psychol Rev

    (1975)
  • R Schmidt

    Motor Control and Learning

    (1998)
  • L Ramig et al.

    Intensive speech treatment for patients with Parkinson's disease: Short- and long-term comparison of two techniques

    Neurology

    (1996)
  • J Elias et al.

    Executive function in Parkinson's disease and subcortical disorders

    Semin Clin Neuropsychiatry

    (1999)
  • C Marsden

    Function of the basal ganglia as revealed by cognitive and motor disorders in Parkinson's disease

    Can J Neurol Sci

    (1984)
  • B Pillon et al.

    Does cognitive impairment in Parkinson's disease result from non-dopaminergic lesions?

    J Neurol Neurosurg Psychiatry

    (1989)
  • Cited by (109)

    • Conversational Vocal Intensity in Parkinson's Disease: Treatment and Environmental Comparisons

      2023, Journal of Voice
      Citation Excerpt :

      Decreased vocal intensity or hypophonia can be an initial speech symptom in PD.6 Hypophonia is attributed partly to hypokinesia (reduced amplitude of movement) and rigidity caused by underlying dopaminergic deficiency.7-12 Abnormalities in central sensory processing (reduced awareness of soft voice), internal cueing (difficulty self-generating increased loudness), and self-monitoring of speech output also contribute to hypophonia.13-22

    • The Impact of Respiratory Exercises on Voice Outcomes: A Systematic Review of the Literature

      2020, Journal of Voice
      Citation Excerpt :

      Respiratory interventions were tested on: individuals with Parkinson disease (PD)29–36; hypotonic children with low vocal intensity levels37; individuals with multiple sclerosis38,39; children with spastic cerebral palsy40; individuals with bilateral vocal nodules41,42; individuals with traumatic motor and sensory complete tetraplegia43; professional voice users with or without reported vocal complaints44–46; individuals with nonspecified dysphonia47; and individuals with MTD.48 Of the eight articles involving individuals with PD, seven were based on the same initial sample of participants.29–35 The two articles on individuals with bilateral vocal nodules,41,42 as well as the two articles on professional classical singers,26,27 were also based on common samples.

    View all citing articles on Scopus
    View full text